Lv1
78 积分 2025-04-03 加入
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
13天前
已完结
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
13天前
已完结
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
15天前
已完结
PDE4B Inhibition: Exploring the Landscape of Chemistry Behind Specific PDE4B Inhibitors, Drug Design, and Discovery
20天前
已完结
Design and development of potent roflumilast analogues targeting PDE-4B: selectivity and pharmacokinetic insights
20天前
已完结
Unlocking the potential of bispecific ADCs for targeted cancer therapy
21天前
已完结
Chemical generation of small molecule-based bispecific antibody-drug conjugates for broadening the target scope
21天前
已完结
Multivalent linkers: A growing trend in antibody–drug conjugate development
22天前
已完结
The Pharmacology of Two Novel Long-Acting Phosphodiesterase 3/4 Inhibitors, RPL554 [9,10-Dimethoxy-2(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2 H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-Dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4 H-pyrimido[6,1-a]isoquinolin-4-one]
22天前
已完结
Novel synthesis and anti-pathogenic properties of ensifentrine and its intermediates against Pseudomonas aeruginosa
23天前
已完结
皖公网安备34019202002308
